Clinical Trials Browser

Terminated × ixazomib × Genitourinary × Clear all

NCT02447887 2019-09-26

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Phase 1/2 Terminated

3 enrolled 1 chart

Carcinoma, Renal Cell